Grant Allen Henderson, MD
Cardiovascular Disease (Cardiology) · Grand Junction
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations · Intermountain Medical Group Grand Junction, LLC · 297 clinicians in this group
Looking this up.
Hospitals listed: Delta County Memorial Hospital · Intermountain Health St. Mary'S Regional Hospital · Montrose Regional Health. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Henderson’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A132955 · Cancelled
Licence status: Cancelled · since 2014 · Columbia University College of Physicians and Surgeons.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Delta County Memorial HospitalDelta, COAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPatients rate it 3 of 5 · 67% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Intermountain Health St. Mary'S Regional HospitalGrand Junction, COAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Intermountain Healthcare, which runs 33 hospitals in 4 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.222, Oct 2024 – Sep 2025
- Montrose Regional HealthMontrose, COAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Hospital Corporation, which runs 20 hospitals in 8 statesPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Delta County Memorial Hospital
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.23 to 2.37) · 116 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.48 to 1.44) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 61 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 19.2 · 27 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 464 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 780 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 735 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.28 (0.72 to 5.85) · 142 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.29 (0.57 to 4.01) · 131 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.42 (0 to 18.07) · 34 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.91 (1.67 to 10.14) · 36 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.07 (0.55 to 3.59) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0 to 1.75) · 544 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.945 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.4 · 86 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 12.8 · 65 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 28.5 · 100 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.6 · 137 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (4 to 9) · 94 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.9 to 15.7) · 94 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.4 to 16.7) · 550 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 178 cases | No different | Jan 2024 – Dec 2024 |
What patients said (223 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 4 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 81% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Intermountain Health St. Mary'S Regional Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.222 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0.03 to 1.87) · 1,161 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.69 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 184.86 (138.36 to 231.36) · 122 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.5 · 95 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.2 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.2 · 271 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.1 · 232 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.5 · 235 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.1 · 382 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,987 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.05 to 0.45) · 4,897 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.06 to 0.45) · 5,033 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.08 (1.2 to 4.96) · 1,953 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.6 (0.11 to 3.1) · 817 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.23 (1.84 to 4.62) · 1,781 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.23 (0.3 to 12.16) · 746 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.86 (0.43 to 7.3) · 773 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.85 (0.42 to 3.29) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.08 (0.41 to 1.75) · 4,037 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.8 · 30 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.701 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.032 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.207 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.129 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 11.8 · 413 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.2 · 334 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -24.7 · 303 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -37.7 · 256 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5.9 · 247 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 368 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.8 to 8) · 133 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (7.8 to 14.3) · 133 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 103 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 146 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.2 to 18.2) · 201 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 691 cases | No different | Jan 2024 – Dec 2024 |
What patients said (980 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Montrose Regional Health
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.06) · 167 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.46 to 1.41) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.6 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.4 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 59 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 19.3 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 595 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.5) · 1,269 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,254 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.53 (1.05 to 6.01) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.22 (0.53 to 3.91) · 308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.97 (0 to 18.93) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.12 (0.82 to 9.41) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 85 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1.62) · 707 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.41 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.987 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 79 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 92 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -15.4 · 74 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -52.7 · 86 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -35.3 · 65 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.5 (4.4 to 9.7) · 130 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (6.9 to 13.6) · 130 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.8 to 17.1) · 445 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.6) · 269 cases | No different | Jan 2024 – Dec 2024 |
What patients said (359 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 5 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 88% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 92% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
Original Medicare doctor bills
$132,664
Medicare paid this office $132,664 for 692 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of aortic valve through the skin and femoral artery | 39 | $22,378 | $574 |
| Repair of mitral valve through the skin, initial prosthesis | 12 | $15,453 | $1,288 |
| Return visit (30+ min) | 134 | $13,676 | $84 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $11,570 | $413 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 66 | $9,559 | $139 |
See all 23 services
| Replacement of aortic valve through the skin and femoral artery | 39 | $22,378 | $574 |
| Repair of mitral valve through the skin, initial prosthesis | 12 | $15,453 | $1,288 |
| Return visit (30+ min) | 134 | $13,676 | $84 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $11,570 | $413 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 66 | $9,559 | $139 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 34 | $8,980 | $264 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 44 | $7,918 | $176 |
| New patient visit (60+ min) | 20 | $3,140 | $157 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 280 | $2,919 | $9 |
| Ultrasound of heart with probe in esophagus, with report | 31 | $2,854 | $71 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 45 | $2,304 | $51 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 30 | $2,224 | $72 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 229 | $1,594 | $5 |
| Shockwave destruction of calcified plaque in coronary artery accessed through skin using catheter | 12 | $1,354 | $113 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $1,020 | $57 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 92 | $961 | $9 |
| Short return visit (20+ min) | 11 | $656 | $55 |
| Ultrasound of heart, follow-up | 14 | $290 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $286 | $15 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $217 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18 | $185 | $10 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $61 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $55 | $2 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 42 | More than 77% of doctors who do this |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
692 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 17% · Women 45% · Also on Medicaid 10% · Health risk score 1.63. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 53% · Heart failure 43% · Atrial fibrillation 41% · Diabetes 30% · Chronic kidney disease 30% · Depression 23% · COPD 22% · Cancer 16% · Stroke 12% · Dementia 8%.
The office billed $456,672, Medicare allowed $176,071 and paid $132,664; for 1,560 services of 70 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 692 | 1,560 | 76 | 1.63 | $456,672 | $132,664 |
| 2023 | 845 | 1,897 | 75 | 1.57 | $436,879 | $129,319 |
| 2022 | 314 | 642 | 75 | 1.50 | $156,791 | $47,025 |
| 2017 | 30 | 33 | 63 | 5.76 | $19,795 | $5,675 |
| 2016 | 15 | 15 | 59 | 3.58 | $8,635 | $2,439 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 26 services
| Return visit (30+ min) | 139 | $19,833 | $93 |
| Replacement of aortic valve through the skin and femoral artery | 27 | $15,590 | $577 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $10,781 | $415 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 54 | $8,242 | $150 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 31 | $7,998 | $258 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 40 | $6,873 | $172 |
| New patient visit (60+ min) | 29 | $4,903 | $169 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 19 | $4,078 | $215 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 308 | $4,060 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 69 | $3,730 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 323 | $2,729 | $6 |
| Injection, regadenoson, 0.1 mg | 16 | $2,605 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,417 | $134 |
| Ultrasound of heart with probe in esophagus, with report | 30 | $2,311 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,915 | $91 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 24 | $1,755 | $70 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,424 | $102 |
| External shock to heart to regulate heart beat | 16 | $1,367 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,189 | $54 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 107 | $1,057 | $9 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 14 | $574 | $41 |
| Ultrasound of heart, follow-up | 15 | $294 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $217 | $15 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $185 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $143 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $54 | $2 |
2022: 12 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $7,101 | $418 |
| New patient visit (45+ min) | 37 | $4,720 | $128 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $2,980 | $81 |
| Return visit (30+ min) | 29 | $2,890 | $100 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $2,872 | $179 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $2,362 | $157 |
| Long return visit (40+ min) | 12 | $1,781 | $137 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 113 | $1,219 | $11 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 14 | $1,182 | $74 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 116 | $1,032 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $832 | $55 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $248 | $10 |
2017: 1 service
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,532 | $181 |
Medicaid work
$3,035 in 2024
Medicaid paid $3,035 for 353 billed services this clinician did in 2024, up to 98 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 338 | $2,839 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 15 | $196 |
| 2024 | 353 | 2 | 98 | $3,035 |
| 2023 | 484 | 4 | 67 | $6,374 |
| 2022 | 91 | 2 | 26 | $907 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 364 | $2,602 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 28 | $1,479 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 79 | $1,211 |
| Return visit (30+ min) | 13 | $1,082 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 63 | $487 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 28 | $420 |
Drugs they prescribed that Part D paid
$101,671
Pharmacies billed $101,671 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 695) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
590 generic and 105 brand-name prescriptions · $101,671 in drug cost · 22 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 26 | $38,781 | $1,492 |
| Eliquis | 21 | $22,758 | $1,084 |
| Ozempic | 12 | $11,243 | $937 |
| Repatha Sureclick | 15 | $8,322 | $555 |
| Xarelto | 12 | $7,416 | $618 |
See all 20 drugs
| Jardiance | 26 | $38,781 | $1,492 |
| Eliquis | 21 | $22,758 | $1,084 |
| Ozempic | 12 | $11,243 | $937 |
| Repatha Sureclick | 15 | $8,322 | $555 |
| Xarelto | 12 | $7,416 | $618 |
| Metoprolol | 61 | $771 | $13 |
| Atorvastatin | 73 | $752 | $10 |
| Clopidogrel | 75 | $744 | $10 |
| Spironolactone | 43 | $417 | $10 |
| Furosemide | 30 | $246 | $8 |
| Potassium Chloride | 18 | $239 | $13 |
| Losartan | 32 | $227 | $7 |
| Rosuvastatin | 32 | $211 | $7 |
| Lisinopril | 41 | $180 | $4 |
| Carvedilol | 35 | $164 | $5 |
| Amlodipine Besylate | 30 | $113 | $4 |
| Isosorbide Mononitrate Er | 18 | $106 | $6 |
| Amiodarone | 14 | $60 | $4 |
| Torsemide | 13 | $42 | $3 |
| Amoxicillin | 15 | $18 | $1 |
Year by year
| 2024 | 695 | 189 | 0% (0) | 15% | $101,671 |
| 2023 | 658 | 162 | 0% (0) | 12% | $82,630 |
| 2022 | 181 | 77 | 0% (0) | 12% | $19,120 |
| 2021 | 129 | 64 | 0% (0) | 14% | $10,687 |
| 2020 | 51 | 32 | 0% (0) | None | $2,439 |
| 2019 | 114 | 19 | 0% (0) | 15% | $5,872 |
| 2018 | 60 | 26 | 0% (0) | None | $2,913 |
| 2017 | 45 | 17 | None | None | $1,319 |
| 2016 | 30 | None | 0% (0) | None | $1,398 |
| 2015 | 36 | None | 0% (0) | 0% | $1,156 |
| 2014 | 28 | None | 0% (0) | None | $507 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Eliquis | 28 | $27,344 | $977 |
| Jardiance | 13 | $14,641 | $1,126 |
| Xarelto | 13 | $14,451 | $1,112 |
| Atorvastatin | 92 | $1,388 | $15 |
| Clopidogrel | 84 | $1,380 | $16 |
| Metoprolol | 73 | $1,371 | $19 |
| Spironolactone | 36 | $490 | $14 |
| Losartan | 15 | $260 | $17 |
| Rosuvastatin | 16 | $229 | $14 |
| Lisinopril | 42 | $228 | $5 |
| Carvedilol | 38 | $228 | $6 |
| Amlodipine Besylate | 39 | $221 | $6 |
| Furosemide | 34 | $217 | $6 |
| Metoprolol | 15 | $67 | $4 |
2022: 4 drugs
| Clopidogrel | 35 | $630 | $18 |
| Metoprolol | 17 | $353 | $21 |
| Atorvastatin | 30 | $352 | $12 |
| Lisinopril | 14 | $65 | $5 |
2021: 3 drugs
| Clopidogrel | 60 | $980 | $16 |
| Atorvastatin | 11 | $252 | $23 |
| Cephalexin | 18 | $68 | $4 |
2020: 1 drug
| Clopidogrel | 31 | $423 | $14 |
2019: 2 drugs
| Torsemide | 14 | $405 | $29 |
| Spironolactone | 12 | $119 | $10 |
2016: 1 drug
| Atorvastatin | 12 | $472 | $39 |
2015: 3 drugs
| Metformin | 12 | $423 | $35 |
| Atorvastatin | 11 | $401 | $36 |
| Glyburide | 13 | $332 | $26 |
2014: 2 drugs
| Glyburide | 12 | $194 | $16 |
| Metformin | 12 | $73 | $6 |
Money from drug and device companies
$5,565 in 2025
| 2025 | 6 | 39 | None | $5,565 |
| 2024 | 10 | 29 | None | $1,052 |
| 2023 | 9 | 36 | None | $2,802 |
| 2022 | 8 | 37 | None | $2,272 |
| 2021 | 5 | 9 | None | $410 |
| 2020 | 2 | 2 | None | $111 |
| 2019 | 3 | 3 | None | $196 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Triclip | $2,917 | 11 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $2,254 | 20 payments
|
| Medical Device Business Services | Stratafix | $137 | 1 payment
|
| Boston Scientific | Wolverine Coronary Cutting Balloon | $105 | 3 payments
|
| Medtronic | Corevalve Evolut R | $85 | 2 payments
|
| Abiomed | None | $67 | 2 payments
|
See all 39 published payments
| Edwards Lifesciences | Meals · 2025-12-18 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $31 |
| Abbott Laboratories | Travel · 2025-12-01 | Navitor | $566 |
| Edwards Lifesciences | Meals · 2025-11-25 | None | $3 |
| Abbott Laboratories | Travel · 2025-11-19 | Amplatzer | $655 |
| Boston Scientific | Meals · 2025-11-06 | Wolverine Coronary Cutting Balloon | $45 |
| Edwards Lifesciences | Travel · 2025-09-30 | None | $190 |
| Edwards Lifesciences | Travel · 2025-09-30 | None | $187 |
| Edwards Lifesciences | Travel · 2025-09-30 | None | $202 |
| Edwards Lifesciences | Meals · 2025-09-30 | None | $70 |
| Edwards Lifesciences | Meals · 2025-09-30 | None | $31 |
| Edwards Lifesciences | Meals · 2025-09-30 | None | $70 |
| Edwards Lifesciences | Meals · 2025-09-30 | None | $31 |
| Edwards Lifesciences | Meals · 2025-09-23 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $47 |
| Edwards Lifesciences | Travel · 2025-09-22 | None | $533 |
| Edwards Lifesciences | Travel · 2025-09-22 | None | $411 |
| Edwards Lifesciences | Meals · 2025-09-17 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $15 |
| Edwards Lifesciences | Meals · 2025-08-19 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $42 |
| Abiomed | Meals · 2025-08-18 | None | $21 |
| Edwards Lifesciences | Meals · 2025-08-15 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $41 |
| Edwards Lifesciences | Meals · 2025-08-13 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $196 |
| Medtronic | Meals · 2025-07-10 | Corevalve Evolut R | $44 |
| Edwards Lifesciences | Meals · 2025-07-01 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $21 |
| Edwards Lifesciences | Meals · 2025-06-26 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $38 |
| Medtronic | Meals · 2025-06-05 | Corevalve Evolut R | $41 |
| Abbott Laboratories | Meals · 2025-05-30 | Mitraclip | $18 |
| Abbott Laboratories | Meals · 2025-05-22 | Mitraclip | $87 |
| Boston Scientific | Meals · 2025-05-20 | Watchman Flx | $24 |
| Medical Device Business Services | Education · 2025-04-24 | Stratafix | $137 |
| Edwards Lifesciences | Meals · 2025-04-21 | Sapien 3 Ultra Resilia | $48 |
| Abiomed | Meals · 2025-04-14 | None | $46 |
| Edwards Lifesciences | Meals · 2025-04-10 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $44 |
| Abbott Laboratories | Travel · 2025-04-03 | Triclip | $992 |
| Abbott Laboratories | Travel · 2025-04-03 | Triclip | $9 |
| Boston Scientific | Meals · 2025-03-21 | Wolverine Coronary Cutting Balloon | $36 |
| Abbott Laboratories | Meals · 2025-03-21 | Triclip | $76 |
| Abbott Laboratories | Meals · 2025-03-21 | Triclip | $98 |
| Abbott Laboratories | Meals · 2025-03-21 | Triclip | $78 |
| Abbott Laboratories | Travel · 2025-03-21 | Triclip | $304 |
| Abbott Laboratories | Meals · 2025-03-17 | Mitraclip | $35 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,052
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $357 | 5 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $186 | 9 payments
|
| Biosense Webster | Carto 3 | $136 | 1 payment
|
| Boston Scientific | Synergy | $115 | 3 payments
|
| Abbott Laboratories | Mitraclip | $74 | 3 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $65 | 3 payments
|
| Medtronic | Corevalve Evolut R | $55 | 2 payments
|
| Abiomed | Impella | $29 | 1 payment
|
| AngioDynamics | Angiovac | $22 | 1 payment
|
| Amgen | Repatha | $14 | 1 payment
|
2023: $2,802
| Edwards Lifesciences | Pascal | $1,998 | 13 payments
|
| Abbott Laboratories | Mitraclip | $489 | 10 payments
|
| Medtronic | Corevalve Evolut R | $82 | 2 payments
|
| Abiomed | Impella | $60 | 1 payment
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $52 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $50 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $36 | 2 payments
|
| Amgen | Repatha | $20 | 1 payment
|
| Boston Scientific | Watchman Access System | $16 | 1 payment
|
2022: $2,272
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $1,470 | 13 payments
|
| Abbott Laboratories | Mitraclip | $419 | 12 payments
|
| Medtronic | Corevalve Evolut R | $201 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $65 | 3 payments
|
| Cardiovascular Systems | Diamondback Coronary | $44 | 3 payments
|
| Boston Scientific | Watchman Access System | $33 | 2 payments
|
| Terumo Medical | Navicross | $24 | 1 payment
|
| Pfizer | Eliquis | $17 | 1 payment
|
2021: $410
| Boston Scientific | Synergy | $133 | 2 payments
|
| Shockwave Medical | Vascular Lithotripsy | $117 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $93 | 2 payments
|
| Cardiovascular Systems | Diamondback Coronary | $44 | 3 payments
|
| Abbott Laboratories | Dragonfly Oct | $23 | 1 payment
|
2020: $111
| Inari Medical | Flowtriever | $95 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $16 | 1 payment
|
2019: $196
| Penumbra | Indigo | $164 | 1 payment
|
| LivaNova USA | Tandemheart | $16 | 1 payment
|
| Siemens Medical Solutions USA | Sc2000 | $16 | 1 payment
|
Professional record
- NPI
- 1447592159
- Licence
- CA A132955California A132955: Cancelled
- Trained
- Columbia University College of Physicians and Surgeons, 2013
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Lane 154, Stanford, CA, 94305
- NPI first listed
- 2013-03-20
- NPI last updated
- 2016-07-05
This is when the NPI record was last certified, not a medical board exam.